Trimi Tirzepatide Review: Cost, Compounded vs Brand & Honest Verdict (2026)

Trimi is a direct-to-patient telehealth program built around one membership rather than a medication fee bolted onto a second subscription: compounded tirzepatide on a single $229/month all-in price, shipped free to all 50 states — usually within about a day of approval. This review covers what Trimi is, what it dispenses, the compounded-versus-brand distinction, its pricing, and how it stacks up. We disclose an affiliate relationship with Trimi; it never changes our scoring, and every fact here comes from Trimi's own program.

What Trimi is

Trimi is a telehealth program whose defining feature is its single-membership model. A U.S.-licensed prescriber reviews an online intake and, if appropriate, compounded tirzepatide ships free to all 50 states — typically within roughly 24 hours of approval. Semaglutide is offered on the same membership. The point of the model is predictability: the tirzepatide price is the all-in monthly figure, rather than a base price plus a separate membership and surprise add-ons that you only discover later.

The compounded-vs-brand question

Two very different products share the name tirzepatide:

• •Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
• •Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

Trimi dispenses compounded tirzepatide, which is why its $229/month sits below brand pricing. That distinction matters more in 2026: the FDA declared the tirzepatide shortage resolved in October 2024, and the enforcement discretion that permitted routine large-scale compounding ended in early 2025 (around February 18, 2025 for 503A pharmacies, March 19, 2025 for 503B outsourcing facilities) — the full timeline is in our guide to whether compounded tirzepatide is still legal in 2026. One Trimi-specific caveat: the dispensing compounding pharmacy is not publicly named on the site, so you cannot vet it in advance.

What Trimi costs in 2026

Trimi's price is a single $229/month membership that covers the visit, the compounded medication, and free nationwide shipping — with no separate medication-plus-membership stack. That is the model's real virtue: because there is one number rather than two, the true monthly total stays predictable as you titrate up. The honest counterpoint is that $229/month is more than the cheapest compounders for the same molecule — for example, CoreAge Rx's flat $149/month.

For context on the brand drug, LillyDirect sells brand Zepbound self-pay vials at roughly $299–$449/month depending on dose (prices effective February 23, 2026; 28-day supply). Trimi's compounded price undercuts that, but you are comparing a non-FDA-approved product to the approved one. For the full cash-price picture, see our Zepbound cost and savings guide.

How the care model holds up

Trimi's strengths are the one-membership simplicity (no stacked fee, so the monthly total is predictable), 50-state shipping usually within about 24 hours of approval, and free shipping. The trade-offs: at $229/month it costs more than CoreAge's flat $149 for the same molecule; the tirzepatide is compounded and not FDA-approved; the compounding pharmacy is not publicly named; and it is injectable only — no oral or brand-name pathway. As with any GLP-1 service, confirm continuity of care and read the cancellation terms; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Separate the provider from the medication, and the brand molecule from a compounded copy. Brand tirzepatide's efficacy is trial-grade: in the 72-week SURMOUNT-1 trial, adults without diabetes lost on average roughly 15% to 21% of body weight across the 5–15 mg doses, versus about 3% on placebo¹; against semaglutide in SURMOUNT-5, tirzepatide produced significantly greater weight loss — about 20% versus 14%². Those results were established with the brand molecule; compounded versions were never tested in those trials, so the trial efficacy cannot simply be assumed to transfer. The full picture is in our tirzepatide evidence guide.

The honest verdict

Trimi is a good fit if you value a genuinely single, predictable all-in price and fast 50-state shipping, and you are comfortable with a compounded, non-FDA-approved product. Its one-membership model avoids the stacked medication-plus-membership fee that trips up buyers at several rivals. The reservations are that $229/month is above the cheapest compounders (CoreAge Rx is a flat $149), the pharmacy is not named, and it is injectable-only. If price is your top priority for compounded tirzepatide, CoreAge undercuts Trimi with included support; if you specifically want brand tirzepatide, price it against LillyDirect. See our best tirzepatide providers ranking and best place to get Zepbound online roundup.